Madrigal Pharmaceuticals Inc (MDGL)

319.69 +5.91 (+1.88%) USD  |  NASDAQ  |  Jan 03, 16:00
319.00 -0.69 (-0.22%) After-Hours: 20:00
More

Madrigal Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics Inc --
89bio Inc --
ADMA Biologics Inc --
Matinas BioPharma Holdings Inc --
Viking Therapeutics Inc --